NICE has recommended natalizumab for adults with highly active RRMS, citing pregnancy suitability, biosimilar value and NHS ...

NICE has recommended Tysabri and biosimilar Tyruko as an option for patients with highly active relapsing-remitting multiple ...

From pricing and demand to regulation and risk, inside the business of psychedelic retreats catering to business leaders.

Many clinical trials to test the use of psychedelic medicines for conditions such as depression have been underway since 2022 ...

CYB003/CYB004 clinical catalysts into 2026, $248M cash runway, equity raises risk, valuation optionality. Click for this CYBN ...

Silicon Valley has a long history with psychedelics, and some of its best-known leaders have tried, like Bill Gates, Sam ...

The California Department of Public Health has warned consumers not to eat TRE House brand “Magic Mushroom” gummies, ...

St. Joseph's Healthcare Hamilton launched a centre that looks at how psychedelics might be useful in medicine.

As 2025 comes to a close, the cannabis world is reflecting on the sometimes dizzying series of political, legal and cultural ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International stock ...

Naltrexone has long been used to treat alcohol use disorder. Now it’s gaining attention as a tool for people who want to cut ...